A Phase IV Post Approval Clinical Study of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

January 14, 2022

Study Completion Date

January 14, 2022

Conditions
Bone Metastasis
Interventions
DEVICE

ExAblate MRgFUS

Focused Ultrasound Ablation

Trial Locations (9)

10065

Weill Cornell Medical Center, New York

19111

Fox Chase Cancer Center, Philadelphia

22908

University of Virginia, Charlottesville

55905

Mayo Clinic, Rochester

77030

MD Anderson, Houston

90024

University of California Los Angeles, Los Angeles

91010

City of Hope, Duarte

94107

University of California San Francisco, San Francisco

94305

Stanford University School of Medicine, Stanford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

InSightec

INDUSTRY